Malaysia - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Containing Insulin Price in Malaysia - 2022
Contents:
- Medicaments Containing Insulin Price in Malaysia (FOB) - 2022
- Medicaments Containing Insulin Price in Malaysia (CIF) - 2022
- Medicaments Containing Insulin Exports in Malaysia
- Medicaments Containing Insulin Imports in Malaysia
Medicaments Containing Insulin Price in Malaysia (FOB) - 2022
In 2022, the average medicaments containing insulin export price amounted to $118,806 per ton, falling by -26.7% against the previous year. Over the period under review, the export price, however, saw a buoyant expansion. The most prominent rate of growth was recorded in 2018 an increase of 171% against the previous year. The export price peaked at $162,158 per ton in 2021, and then shrank dramatically in the following year.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Papua New Guinea ($127,882 per ton), while the average price for exports to Brunei Darussalam amounted to $74,583 per ton.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Papua New Guinea (+8.6%), while the prices for the other major destinations experienced mixed trend patterns.
Medicaments Containing Insulin Price in Malaysia (CIF) - 2022
In 2022, the average medicaments containing insulin import price amounted to $24,787 per ton, picking up by 2.8% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +2.2%. The most prominent rate of growth was recorded in 2018 an increase of 30% against the previous year. The import price peaked in 2022 and is expected to retain growth in the near future.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the UK ($37,472 per ton), while the price for Japan ($1,679 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Australia (-0.9%), while the prices for the other major suppliers experienced a decline.
Medicaments Containing Insulin Exports in Malaysia
In 2022, shipments abroad of medicaments containing insulin but not antibiotics decreased by 0% to 36 kg for the first time since 2018, thus ending a three-year rising trend. Over the period under review, exports showed significant growth. The growth pace was the most rapid in 2021 with an increase of 89%. Over the period under review, the exports attained the maximum in 2022 and are likely to see steady growth in the immediate term.
In value terms, medicaments containing insulin exports contracted remarkably to $4.3K in 2022. In general, exports recorded a significant increase. The growth pace was the most rapid in 2021 with an increase of 122%. As a result, the exports attained the peak of $5.9K, and then fell remarkably in the following year.
| Export of Medicaments Containing Insulin in Malaysia (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Papua New Guinea | 1.2 | 2.1 | 3.9 | 3.8 | 46.8% |
| Brunei Darussalam | 0.2 | 0.3 | 0.5 | 0.5 | 35.7% |
| Others | N/A | 0.2 | 1.5 | N/A | 650.0% |
| Total | 1.3 | 2.7 | 5.9 | 4.3 | 49.0% |
Top Export Markets for Medicaments Containing Insulin from Malaysia in 2022:
- Papua New Guinea (30.0 kg)
- Brunei Darussalam (6.0 kg)
Medicaments Containing Insulin Imports in Malaysia
In 2022, overseas purchases of medicaments containing insulin but not antibiotics decreased by -4.9% to 38 tons, falling for the second year in a row after two years of growth. Over the period under review, imports saw a mild contraction. The growth pace was the most rapid in 2020 when imports increased by 0.3%. As a result, imports reached the peak of 40 tons. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.
In value terms, medicaments containing insulin imports contracted modestly to $952K in 2022. The total import value increased at an average annual rate of +2.3% over the period from 2019 to 2022; the trend pattern remained consistent, with only minor fluctuations in certain years. The pace of growth appeared the most rapid in 2020 when imports increased by 4.7% against the previous year.
| Import of Medicaments Containing Insulin in Malaysia (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| United Kingdom | 469 | 514 | 562 | 572 | 6.8% |
| Australia | 410 | 407 | 402 | 370 | -3.4% |
| Japan | 2.4 | 2.5 | 2.6 | 2.5 | 1.4% |
| Others | 5.7 | 6.4 | 7.2 | 7.6 | 10.1% |
| Total | 888 | 930 | 974 | 952 | 2.3% |
Top Suppliers of Medicaments Containing Insulin to Malaysia in 2022:
- Australia (21.4 tons)
- United Kingdom (15.3 tons)
- Japan (1.5 tons)
This report provides an in-depth analysis of the medicaments containing insulin market in Malaysia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
- Malaysia
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Malaysia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
310
This report provides an in-depth analysis of the medicaments containing insulin market in Malaysia.
368
This report provides an in-depth analysis of the medicaments containing hormones market in Malaysia.
361
This report provides an in-depth analysis of the medicaments containing penicillin market in Malaysia.
171
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Malaysia.
205
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Malaysia.
311
This report provides an in-depth analysis of the market for medicaments of other antibiotics in Malaysia.
479
This report provides an in-depth analysis of the global medicaments containing insulin market.
485
This report provides an in-depth analysis of the global medicaments containing hormones market.
579
This report provides an in-depth analysis of the global medicaments containing penicillin market.
308
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
103
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
103
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
